• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动眼神经功能与帕金森病的运动及非运动症状相关。

Oculomotor Performances Are Associated With Motor and Non-motor Symptoms in Parkinson's Disease.

作者信息

Zhang Yu, Yan Aijuan, Liu Bingyu, Wan Ying, Zhao Yuchen, Liu Ying, Tan Jiangxiu, Song Lu, Gu Yong, Liu Zhenguo

机构信息

Department of Neurology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Key Laboratory of Primate Neurobiology, CAS Center for Excellence in Brain Science and Intelligence Technology, Institute of Neuroscience, Chinese Academy of Sciences, Shanghai, China.

出版信息

Front Neurol. 2018 Nov 28;9:960. doi: 10.3389/fneur.2018.00960. eCollection 2018.

DOI:10.3389/fneur.2018.00960
PMID:30546341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6280559/
Abstract

Parkinson's disease (PD) patients exhibit deficits in oculomotor behavior, yet the results are inconsistent across studies. In addition, how these results are associated with clinical symptoms is unclear, especially in China. We designed a case-control study in China including 37 PD patients and 39 controls. Clinical manifestations in PD patients were recorded. Oculomotor performance was measured by a video-based eye tracker system. We found that six oculomotor parameters, including fixation stability, saccadic latency, smooth pursuit gain, saccade frequency, viewing range, and saccade frequency during free-viewing context, were significantly different in PD patients and control group. Combining application of these six parameters could improve diagnostic accuracy to over 90%. Moreover, pursuit gain was significantly associated with PD duration, UPDRS III, in PD patients. Saccade latency was significantly associated with PD duration, Berg balance score, RBD score, and Total LEDD in PD patients. PD patients commonly exhibit oculomotor deficits in multiple behavioral contexts, which are associated with both motor and non-motor symptoms. Oculomotor test may provide a valuable tool for the clinical assessment of PD.

摘要

帕金森病(PD)患者存在眼球运动行为缺陷,但各研究结果并不一致。此外,这些结果与临床症状之间的关联尚不清楚,在中国尤其如此。我们在中国设计了一项病例对照研究,纳入37例PD患者和39名对照。记录PD患者的临床表现。通过基于视频的眼动追踪系统测量眼球运动表现。我们发现,包括注视稳定性、扫视潜伏期、平稳跟踪增益、扫视频率、视野范围以及自由观看时的扫视频率在内的六个眼球运动参数在PD患者和对照组之间存在显著差异。联合应用这六个参数可将诊断准确率提高到90%以上。此外,在PD患者中,跟踪增益与病程、统一帕金森病评定量表第三部分(UPDRS III)显著相关。扫视潜伏期与PD患者的病程、伯格平衡量表评分、快速眼球运动睡眠行为障碍(RBD)评分以及左旋多巴等效剂量总和(Total LEDD)显著相关。PD患者通常在多种行为情境中表现出眼球运动缺陷,这些缺陷与运动和非运动症状均有关联。眼球运动测试可能为PD的临床评估提供一个有价值的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c01/6280559/246d06733d74/fneur-09-00960-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c01/6280559/048ff2a85978/fneur-09-00960-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c01/6280559/246d06733d74/fneur-09-00960-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c01/6280559/048ff2a85978/fneur-09-00960-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c01/6280559/246d06733d74/fneur-09-00960-g0002.jpg

相似文献

1
Oculomotor Performances Are Associated With Motor and Non-motor Symptoms in Parkinson's Disease.动眼神经功能与帕金森病的运动及非运动症状相关。
Front Neurol. 2018 Nov 28;9:960. doi: 10.3389/fneur.2018.00960. eCollection 2018.
2
Eye movement especially vertical oculomotor impairment as an aid to assess Parkinson's disease.眼球运动,尤其是垂直眼球运动障碍,可作为评估帕金森病的辅助手段。
Neurol Sci. 2021 Jun;42(6):2337-2345. doi: 10.1007/s10072-020-04796-6. Epub 2020 Oct 12.
3
Clinical and Oculomotor Correlates With Freezing of Gait in a Chinese Cohort of Parkinson's Disease Patients.中国帕金森病患者队列中步态冻结的临床及动眼神经相关性
Front Aging Neurosci. 2020 Jul 31;12:237. doi: 10.3389/fnagi.2020.00237. eCollection 2020.
4
Oculomotor impairments in Parkinson's disease.帕金森病中的动眼神经障碍
Front Aging Neurosci. 2022 Nov 9;14:985679. doi: 10.3389/fnagi.2022.985679. eCollection 2022.
5
Istradefylline Improves Impaired Smooth Pursuit Eye Movements in Parkinson's Disease.异他茶碱改善帕金森病中受损的平稳跟踪眼球运动。
Neurol Ther. 2023 Oct;12(5):1791-1798. doi: 10.1007/s40120-023-00509-1. Epub 2023 Jun 17.
6
Abnormal eye movements in Parkinson's disease: From experimental study to clinical application.帕金森病中的异常眼动:从实验研究到临床应用
Parkinsonism Relat Disord. 2023 Oct;115:105791. doi: 10.1016/j.parkreldis.2023.105791. Epub 2023 Jul 29.
7
Objective assessment of eye alignment and disparity-driven vergence in Parkinson's disease.帕金森病中眼位对准和视差驱动性聚散的客观评估。
Front Aging Neurosci. 2023 Oct 31;15:1217765. doi: 10.3389/fnagi.2023.1217765. eCollection 2023.
8
The association between alterations of eye movement control and cerebral intrinsic functional connectivity in Parkinson's disease.帕金森病中眼球运动控制改变与脑内固有功能连接之间的关联。
Brain Imaging Behav. 2016 Mar;10(1):79-91. doi: 10.1007/s11682-015-9367-7.
9
Smooth Pursuit and Reflexive Saccade in Discriminating Multiple-System Atrophy With Predominant Parkinsonism From Parkinson's Disease.平稳跟踪和反射性扫视在鉴别帕金森叠加综合征与帕金森病中的应用
J Clin Neurol. 2024 Mar;20(2):194-200. doi: 10.3988/jcn.2022.0413. Epub 2024 Jan 1.
10
Eye movement control during visual pursuit in Parkinson's disease.帕金森病患者视觉追踪过程中的眼球运动控制
PeerJ. 2018 Aug 22;6:e5442. doi: 10.7717/peerj.5442. eCollection 2018.

引用本文的文献

1
Naturalistic Eye Movement Tasks in Parkinson's Disease: A Systematic Review.帕金森病的自然主义眼动任务:系统评价。
J Parkinsons Dis. 2024;14(7):1369-1386. doi: 10.3233/JPD-240092.
2
Effectiveness of vestibular rehabilitation on postural balance in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials.前庭康复对帕金森病患者姿势平衡的疗效:系统评价和随机对照试验的荟萃分析。
BMC Neurol. 2024 May 14;24(1):161. doi: 10.1186/s12883-024-03649-5.
3
Effectiveness of Yijinjing on cognitive and motor functions in patients with Parkinson's disease: study protocol for a randomized controlled trial.

本文引用的文献

1
Superoxide Radical Dismutation as New Therapeutic Strategy in Parkinson's Disease.超氧化物歧化作为帕金森病的新治疗策略
Aging Dis. 2018 Aug 1;9(4):716-728. doi: 10.14336/AD.2017.1018. eCollection 2018 Aug.
2
Combined measurement of plasma cystatin C and low-density lipoprotein cholesterol: A valuable tool for evaluating progressive supranuclear palsy.联合检测血浆半胱氨酸蛋白酶抑制剂 C 和低密度脂蛋白胆固醇:评估进行性核上性麻痹的有价值工具。
Parkinsonism Relat Disord. 2018 Jul;52:37-42. doi: 10.1016/j.parkreldis.2018.03.014. Epub 2018 Mar 19.
3
Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson's Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage.
易筋经对帕金森病患者认知和运动功能的有效性:一项随机对照试验的研究方案
Front Neurol. 2024 Apr 26;15:1357777. doi: 10.3389/fneur.2024.1357777. eCollection 2024.
4
Oculomotor Dysfunction in Idiopathic and LRRK2-Parkinson's Disease and At-Risk Individuals.特发性和 LRRK2 帕金森病及高危个体的眼球运动功能障碍。
J Parkinsons Dis. 2024;14(4):797-808. doi: 10.3233/JPD-230416.
5
Detecting Abnormal Eye Movements in Patients with Neurodegenerative Diseases - Current Insights.检测神经退行性疾病患者的异常眼球运动——当前见解
Eye Brain. 2024 Apr 9;16:3-16. doi: 10.2147/EB.S384769. eCollection 2024.
6
Reduced maximal range of ocular movements and its response to acute levodopa challenge in Parkinson's disease.帕金森病患者眼球运动最大范围减小及其对急性左旋多巴激发试验的反应
Front Aging Neurosci. 2024 Mar 20;16:1368539. doi: 10.3389/fnagi.2024.1368539. eCollection 2024.
7
Joubert Syndrome Presenting With Levodopa-Responsive Parkinsonism.伴有左旋多巴反应性帕金森症的乔布综合征
J Mov Disord. 2024 Jul;17(3):339-341. doi: 10.14802/jmd.23275. Epub 2024 Mar 27.
8
Decoding effects of psychoactive drugs in a high-dimensional space of eye movements in monkeys.在猴子眼动的高维空间中解码精神活性药物的作用。
Natl Sci Rev. 2023 Oct 3;10(11):nwad255. doi: 10.1093/nsr/nwad255. eCollection 2023 Nov.
9
A novel tablet-based software for the acquisition and analysis of gaze and eye movement parameters: a preliminary validation study in Parkinson's disease.一种用于获取和分析注视及眼动参数的新型平板软件:帕金森病的初步验证研究。
Front Neurol. 2023 Jun 15;14:1204733. doi: 10.3389/fneur.2023.1204733. eCollection 2023.
10
Oculomotor impairments in Parkinson's disease.帕金森病中的动眼神经障碍
Front Aging Neurosci. 2022 Nov 9;14:985679. doi: 10.3389/fnagi.2022.985679. eCollection 2022.
三叶因子3、胆碱酯酶和同型半胱氨酸:晚期帕金森病痴呆和血管性帕金森病痴呆的潜在预测指标。
Aging Dis. 2018 Feb 1;9(1):51-65. doi: 10.14336/AD.2017.0416. eCollection 2018 Feb.
4
Eye Movements in Parkinson's Disease and Inherited Parkinsonian Syndromes.帕金森病及遗传性帕金森综合征中的眼球运动
Front Neurol. 2017 Nov 9;8:592. doi: 10.3389/fneur.2017.00592. eCollection 2017.
5
P53 Dysfunction in Neurodegenerative Diseases - The Cause or Effect of Pathological Changes?神经退行性疾病中的P53功能障碍——病理变化的原因还是结果?
Aging Dis. 2017 Jul 21;8(4):506-518. doi: 10.14336/AD.2016.1120. eCollection 2017 Jul.
6
Opposite effects of l-dopa and DBS-STN on saccadic eye movements in advanced Parkinson's disease.左旋多巴和 DBS-STN 对晚期帕金森病眼球运动的相反影响。
Neurol Neurochir Pol. 2017 Sep-Oct;51(5):354-360. doi: 10.1016/j.pjnns.2017.06.002. Epub 2017 Jun 24.
7
On the Relationship between Energy Metabolism, Proteostasis, Aging and Parkinson's Disease: Possible Causative Role of Methylglyoxal and Alleviative Potential of Carnosine.能量代谢、蛋白质稳态、衰老与帕金森病之间的关系:甲基乙二醛的可能致病作用及肌肽的缓解潜力
Aging Dis. 2017 May 2;8(3):334-345. doi: 10.14336/AD.2016.1030. eCollection 2017 May.
8
Cystatin C as a potential therapeutic mediator against Parkinson's disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular units.胱抑素C作为一种潜在的治疗介质,通过血管内皮生长因子诱导的血管生成和增强神经血管单元中的神经元自噬来对抗帕金森病。
Cell Death Dis. 2017 Jun 1;8(6):e2854. doi: 10.1038/cddis.2017.240.
9
Clinical application of eye movement tasks as an aid to understanding Parkinson's disease pathophysiology.眼动任务在辅助理解帕金森病病理生理学方面的临床应用。
Exp Brain Res. 2017 May;235(5):1309-1321. doi: 10.1007/s00221-017-4916-5. Epub 2017 Mar 3.
10
A Novel Immunosuppressor, (5R)-5-Hydroxytriptolide, Alleviates Movement Disorder and Neuroinflammation in a 6-OHDA Hemiparkinsonian Rat Model.一种新型免疫抑制剂,(5R)-5-羟基雷公藤内酯醇,可减轻6-羟基多巴胺半侧帕金森病大鼠模型的运动障碍和神经炎症。
Aging Dis. 2017 Feb 1;8(1):31-43. doi: 10.14336/AD.2016.0929. eCollection 2017 Feb.